Drug resistance in amoebiasis

Indian Journal of Medical Research

Volumn 123, Issue 2, 2006, Pages 115-118

  Bansal, Devendra ^a   Malla, Nancy ^a   Mahajan, R C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Amoebiasis; Emetine; In vitro sensitivity; Metronidazole; Multidrug resistance mechanism

Indexed keywords

AMEBIASIS VACCINE; ANTIPROTOZOAL AGENT; CHLOROQUINE; DIIODOHYDROXYQUIN; DILOXANIDE FUROATE; EMETINE; GLYCOPROTEIN P; METRONIDAZOLE; MULTIDRUG RESISTANCE PROTEIN; NITROIMIDAZOLE DERIVATIVE; ORNIDAZOLE; PAROMOMYCIN; SECNIDAZOLE; TINIDAZOLE;

AMEBIASIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DEVELOPING COUNTRY; DRUG SYNTHESIS; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; HEALTH CARE COST; HUMAN; IN VITRO STUDY; LIVER AMEBIASIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE CONTROL; PARASITE VIRULENCE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; REVIEW; SEQUENCE ANALYSIS; TREATMENT FAILURE;

ANIMALS; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE, MULTIPLE; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; METRONIDAZOLE;

EID: 33645474210     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Amoebiasis. Wkly Epidemiol Rec 1997; 72: 97-9.
2. Walsh AL. Prevalence in Entamoeba histolytica infection. In: Ravdin JI, editor. Amoebiasis: human infection by Entamoeba histolytica. New York: John Wiley & Sons, Inc; 1988 p. 93-105.
3. Tanaka J, Kaneda Y. Seroepidemiology of anti-E. histolytica antibody by ELISA in the greater Tokyo area, Tokai. J Expt Clin Med 1991; 16: 253-8.
4. Haque R, Mollah NA, Ali IK, Alam K, Eubanks A, Lyerly D, et al. Diagnosis of amoebic liver abscess and intestinal infection with the Techlab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol 2000; 38: 3235-9.
5. Blessmann J, Van Linh P, Nu PA, Thi HD, Muller-Myhsok B, Buss H, et al. Epidemiology of amoebiasis in a region of high incidence of amoebic liver abscess in central Vietnam. Am J Trop Med Hyg 2002; 66: 578-83.
6. Kang Q Mathew MS, Rajan DP, Daniel JD, Mathan MM, Mathan VI, et al. Prevalence of intestinal parasites in rural southern Indians. Trop Med Int Health 1998; 3: 70-5.
7. Mahajan RC, Sehgal R, Ganguly NK. Recent developments in amoebiasis research. Indian Rev Life Sci 1991; 11 : 139-67.
8. Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC. Entamoeba histolytica and Entamoeba dispar. epidemiology, and comparison of diagnostic methods in a setting of non endemicity. Clin Infect Dis 1999; 29: 1315-8.
9. Hanna RM, Dahniya MH, Badr SS, El-Betagy A. Percutaneous catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 2000; 5 : 578-81.
10. Burchard GD, Mirelman D. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol 1988; 66: 231-42.
11. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14: 150-64.
12. Adagu IS, Nolder D, Warhurst DC, Rossignol JF. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. J Antimicrob Chemother 2002; 49: 103-11.
13. Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N. In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microbiol Antimicrob 2004; 3: 27-33.
14. Knight R. The chemotherapy of amoebiasis. J Antimicrob Chemother 1980; 6: 577-93.
15. Ravdin JI, Petri WA Jr. Entamoeba histolytica (amoebiasis). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious disease. New York: Churchill Livingstone; 1995 p. 2395-408.
16. Borst P, Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu Rev Microbiol 1995; 49: 427-60.
17. Upcroft JA, Upcroft P. Drug resistance and Giardia. Parasitol Today 1993; 9: 187-90.
18. Johnson PJ. Metronidazole and drug resistance. Parasitol Today 1993; 9 : 183-6.
19. Voolmann T, Boreham PFL. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aus 1993; 159: 490.
20. Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother 1997; 40: 833-40.
21. Prabhu R, Sehgal R, Chakraborti A, Malla N, Ganguly NK, Mahajan RC. Isolation of emetine resistant clones of Entamoeba histolytica by Petri dish agar method. Indian J Med Res 2000; 111: 11-3.
22. Wassmann C, Hellberg A, Tannich E, Bruchhaus I. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of ironcontaining superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 1999; 274: 26051-6.
23. Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med 1987; 316: 1388-93.
24. Fojo A, Akiyana SI, Gottesman MM, Pasten I. Reduced accumulation in multiple drug resistant human KB carcinoma cell lines. Cancer Res 1985; 45 : 3002-7.
25. Gros P, Croop J, Housman D. Mammalian multi-drug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 1986; 47: 371-80.
26. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Goltesman MM, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells. Cell 1986; 47: 381-9.
27. Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 1989; 58: 137-71.
28. Gerlach JH, Endicott JA, Juranka PF, Hendrson G, Sarangi F, Deuchars KL, et al. Homology between P-glycoprotein and a bacterial haemolysis transport protein suggests a model for multidrug resistance. Nature 1986; 324 : 485-9.
29. Roninson IB, Abelson HT, Houseman DE, Howell N, Varshavsky A. Amplification of specific DNA sequence correlates with multi-drug resistance in Chinese hamster cells. Nature 1984; 309: 626-8.
30. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. J Bioenerg Biomembr 1995; 27: 77-84.
31. Cowman AF, Karcz SR. The pfmdr gene homologues of Plasmodium falciparum. Acta Leiden 1991; 60: 121-9.
32. Johnson PJ, Schuck BL, Delgadillo MG. Analysis of a single-domain P-glycoprotein-like gene in the early diverging protist Trichomonas vaginalis. Mol Biochem Parasitol 1994; 66: 127-37.
33. Ouellette M, Papadopoulou B. Mechanisms of drug resistance in Leishmania. Parasitol Today 1993; 9: 150-3.
34. Orozco E, Perez DG, Gomez MC, Ayala P. Multidrug resistance in Entamoeba histolytica. Parasitol Today 1995; 11 : 473-5.
35. Biedler JL. Genetic aspects of multidrug resistance. Cancer 1992; 70 (Suppl) : 1799.
36. Samueloson J, Ayala P, Orozco E, Wirth D. Emetine resistant mutants of E. histolytica overexpresses mRNA for multidrug resistance. Arch Invest Med 1990; 21 : 1893-7.
37. Descouteaux S, Shen PS, Ayala P, Orozco E, Samuelson J. P-glycoprotein genes of Entamoeba histolytica. Arch Med Res 1992; 23 : 23-5.
38. Orozco E, Lopez C, Gomez C, Perez DG, Marchat L, Banuelos C, et al. Multidrug resistance in the protozoan parasite Entamoeba histolytica. Parasite Int 2002; 51 : 353-9.
39. Gomez MDC, Perez DG, Ayala P, Samuelson J, Orozco E. Physiology and molecular biology of multidrug resistance in Entamoeba histolytica. Arch Med Res 1996; 27: 421-5.